RESEARCH LIBRARY

Advancing Natural Language Processing in Educational Assessment

This book examines the use of natural language technology in educational testing, measurement, and assessment. Recent developments in natural language processing (NLP) have enabled large-scale educational applications, though scholars and professionals may lack a shared understanding of the strengths and limitations of NLP in assessment as well as the challenges that testing organizations face in implementation. This first-of-its-kind book provides evidence-based practices for the use of NLP-based approaches to automated text and speech scoring, language proficiency assessment, technology-assisted item generation, gamification, learner feedback, and beyond.

Educational Measurement: Issues and Practice

This short, invited manuscript focuses on the implications for certification and licensure assessment organizations as a result of the wide‐spread disruptions caused by the COVID-19 pandemic. 

Integrating Timing Considerations to Improve Testing Practices

This book synthesizes a wealth of theory and research on time issues in assessment into actionable advice for test development, administration, and scoring. 

Integrating Timing Considerations to Improve Testing Practices

This chapter presents a historical overview of the testing literature that exemplifies the theoretical and operational evolution of test speededness.

Educational Measurement: Issues and Practice, 39: 30-36

This article proposes the conscious weight method and subconscious weight method to bring more objectivity to the standard setting process. To do this, these methods quantify the relative harm of the negative consequences of false positive and false negative misclassification.

Muscle Nerve, 58: 646-654

The Amyotrophic Lateral Sclerosis (ALS)‐Specific Quality of Life instrument and its revised version (ALSSQOL and ALSSQOL‐R) have strong psychometric properties, and have demonstrated research and clinical utility. This study aimed to develop a short form (ALSSQOL‐SF) suitable for limited clinic time and patient stamina.

Qual Life Res 27, 1711–1720 (2018)

The US Food and Drug Administration (FDA), as part of its regulatory mission, is charged with determining whether a clinical outcome assessment (COA) is “fit for purpose” when used in clinical trials to support drug approval and product labeling. This paper provides a review (and some commentary) on the current state of affairs in COA development/evaluation/use with a focus on one aspect: How do you know you are measuring the right thing? In the psychometric literature, this concept is referred to broadly as validity and has itself evolved over many years of research and application.